| Recommendation | |
|---|---|
|
| |
| 11.10 | Include a time-integrated measure of clinical disease severity (such as freedom from CLTI) in the CLTI trial design to describe the total impact of comparator CLTI interventions. |
| Recommendation | |
|---|---|
|
| |
| 11.10 | Include a time-integrated measure of clinical disease severity (such as freedom from CLTI) in the CLTI trial design to describe the total impact of comparator CLTI interventions. |